Caladrius Biosciences, Inc.
(NASDAQ CM: CLBS)
Rigrodsky Law, P.A. is investigating Caladrius Biosciences, Inc. (“Caladrius”) regarding possible breaches of fiduciary duties and other violations of law related to Caladrius’ agreement to merge with Cend Therapeutics, Inc.